UBS Group AG Sells 714,768 Shares of Corteva, Inc. $CTVA

UBS Group AG lessened its stake in shares of Corteva, Inc. (NYSE:CTVA) by 26.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,025,140 shares of the company’s stock after selling 714,768 shares during the period. UBS Group AG’s holdings in Corteva were worth $135,745,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Activest Wealth Management boosted its stake in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares during the last quarter. JPL Wealth Management LLC purchased a new position in shares of Corteva in the third quarter worth $25,000. True Wealth Design LLC raised its stake in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares during the last quarter. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the third quarter worth $29,000. Finally, Jackson Grant Investment Advisers Inc. raised its stake in shares of Corteva by 90.6% in the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.15% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Wall Street Zen cut Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Bank of America boosted their price target on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and boosted their price target for the stock from $75.00 to $77.00 in a research note on Thursday, February 5th. CICC Research boosted their price target on Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 11th. Finally, Mizuho boosted their price target on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $86.38.

Corteva Price Performance

NYSE CTVA opened at $81.12 on Friday. The business’s fifty day moving average price is $80.39 and its 200-day moving average price is $72.05. The stock has a market capitalization of $54.46 billion, a price-to-earnings ratio of 51.34, a PEG ratio of 2.72 and a beta of 0.68. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts predict that Corteva, Inc. will post 3.62 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.